As of 2024, China's share of scientific publications in molecular biology among the world's top 10% cited has steadily increased, with projections indicating growth from 12.65% in 2024 to 14.54% in 2028. This upward trajectory highlights a consistent focus on enhancing research impact and global influence in this domain. Assuming a similar share in 2023, the compound annual growth rate (CAGR) over the next five years is anticipated to align closely with these forecasts, emphasizing increasing citation impact.
Future trends to watch for include:
- Continued investments in molecular biology research infrastructure.
- Strategies to enhance cross-national collaborations and innovation.
- Potential policy changes fostering a conducive research environment.
